US SB288 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 8 2021 - 25% progression, died in committee
Action: 2021-02-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 8 2021 - 25% progression, died in committee
Action: 2021-02-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Title
TRANSPLANT Act of 2021 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021
Sponsors
| Sen. Jack Reed [D-RI] | Sen. Richard Burr [R-NC] | Sen. Tina Smith [D-MN] | Sen. Tim Scott [R-SC] |
| Sen. Tammy Duckworth [D-IL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-02-08 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575) |
Same As/Similar To
HB941 (Same As) 2021-05-26 - Became Public Law No: 117-15.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/288/all-info |
| Text | https://www.congress.gov/117/bills/s288/BILLS-117s288is.pdf |
